Source: World Health Organization (WHO) |

WHO and the International Organisation of the Francophonie (IOF) sign Memorandum of Understanding to strengthen access to health in Francophone countries

Promoting COVID-19 vaccine equity, fighting malaria and advancing universal health coverage are key elements of the memorandum

The World Health Organization and the International Organisation of the Francophonie (IOF) today signed a memorandum of understanding to scale up collaboration and boost access to health services in Francophone countries. The agreement, finalized at a ceremony held at the WHO Headquarters in Geneva, focuses on advancing universal health coverage, fighting…

Source: World Health Organization (WHO) |

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine, 7 April 2021

Events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca COVID-19 vaccine

The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago. At its most recent meeting on 7 April, 2021,…

Source: World Health Organization (WHO) |

WHO urges countries to build a fairer, healthier world post-COVID-19

As countries move forward post-COVID-19, it will be vital to avoid cuts in public spending on health and other social sectors

COVID-19 has unfairly impacted some people more harshly than others, exacerbating existing inequities in health and welfare within and between countries. For World Health Day, 7 April 2021, WHO is therefore issuing five calls for urgent action to improve health for all people. Within countries, illness and death from COVID-19 have been…

Source: World Health Organization (WHO) |

Tunisia receives first batch of COVID-19 vaccines through COVAX Facility

The COVAX Initiative also provided the Ministry of Health with a set of 506,400 syringes and 1,100 safety boxes

Tunisia received today the first batch of 93,600 doses of Pfizer COVID-19 vaccines through the COVAX Facility. This delivery is part of a first wave of arrivals that will continue during the year, with the goal of vaccinating 20% ​​of the population in Tunisia. “This shipment represents an important step…

Source: World Health Organization (WHO) |

Coronavirus - Ghana: COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout

Ghana became the first country outside India to receive COVID-19 vaccine doses shipped via the COVAX Facility

COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week; Final first round of allocations for doses of AstraZeneca/Oxford and Pfizer-BioNTech vaccines, to the majority of countries and economies participating in the COVAX Facility,…

Source: World Health Organization (WHO) |

WHO launches consolidated guidelines for malaria

They are designed to support malaria-affected countries in their efforts to reduce and, ultimately, eliminate a disease that continues to claim more than 400 000 lives each year

The WHO Guidelines for malaria, launched today, bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform (http://bit.ly/3bg8bmF). They are designed to support malaria-affected countries in their efforts to reduce and, ultimately, eliminate a disease that continues to claim more than 400 000 lives each…

Source: World Health Organization (WHO) |

Coronavirus - The Oxford/AstraZeneca COVID-19 vaccine: what you need to know

Vaccination is recommended for persons with comorbidities that have been identified as increasing the risk of severe COVID-19

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine (AZD1222).  Here’s a brief summary; you may access the guidance document here.  Who should be vaccinated first? While vaccine supplies are limited, it is recommended that priority be given…

Source: World Health Organization (WHO) |

Coronavirus: COVAX announces new agreement, plans for first deliveries

COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021

COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements; additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available…

Source: World Health Organization (WHO) |

Emergency Committee on COVID-19 advises on variants, vaccines

The committee urged WHO to develop a standardized system for naming new variants that avoids geographical markers, an area WHO has already begun work on

The COVID-19 pandemic continues to constitute a Public Health Emergency of International Concern (PHEIC), according to the WHO Emergency Committee (EC) on COVID-19. The EC met virtually yesterday (14 January) at the request of WHO Director-General Dr Tedros Adhanom Ghebreyesus to review the emerging variants of SARS-CoV-2, the virus that…

Source: World Health Organization (WHO) |

WHO calls for reinvigorated action to fight malaria

Global malaria gains threatened by access gaps, COVID-19 and funding shortfalls

The World Health Organization (WHO) is calling on countries and global health partners to step up the fight against malaria, a preventable and treatable disease that continues to claim hundreds of thousands of lives each year. A better targeting of interventions, new tools and increased funding are needed to change…